Medprime Technologies, a healthcare diagnostics company, has completed its Pre-Series A funding round, with investment led by Ashish Kacholia, co-founder of Hungama Digital and a prominent Indian investor. The funds will drive Medprime’s international growth, particularly focusing on expanding its digital microscopy solution, CILIKA. The investment will also enable the launch of advanced AI modules for its MICALYS platform, enhancing the company’s medical diagnostics capabilities in India.
Medprime plans to use the funds to upgrade its manufacturing processes, aiming to improve efficiency and scale production to meet the growing global demand. The company has established itself in the field of digital microscopy, with its products being used by top Indian institutions such as AIIMS, Maulana Azad Medical College, Banaras Hindu University, and Apollo Diagnostics. These partnerships underscore the widespread adoption of Medprime’s technology in the healthcare sector.
Ashish Kacholia noted the importance of Medprime’s work, saying that the future of healthcare lies in the integration of technology and medicine. He expressed confidence that this partnership would result in significant advancements in medical diagnostics.
Greeshma Unnikrishnan, co-founder of Medprime, highlighted the strategic value of the investment, stating that Kacholia’s support aligns with the company’s mission to revolutionize healthcare through innovation. The funding will allow Medprime to further enhance its AI capabilities and improve operational scalability, making its solutions more accessible to healthcare providers globally.
Founded in 2014 by four IIT Bombay biomedical engineering graduates, Medprime has received backing from various organizations, including SAMRIDH, USAID, BIRAC, and incubators like SINE and Venture Centre. Medprime’s growth has also been supported by venture capital firms such as Lavni Ventures, Riso Capital, and Mumbai Angels. S Dayma & Co acted as the legal and financial advisor to Ashish Kacholia for this transaction.
